Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
Discover the impact of therapy on MS by tracking inflammatory polyfunctionality in monocytes
Uncover NK contribution to Crohn's disease through proinflammatory polyfunctionality
Reveal the striking heterogeneity of polyfunctionality in PMF patient granulocytes suggesting directions for therapy in MPNA